FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Viona Pharmaceuticals Dapsone Gel 7 Recall

Dapsone Gel 7

VIONA PHARMACEUTICALS INC · Cranford, NJ

Risk level
Class II
Reported by FDA
Jan 8, 2025
Recall ID
D-0171-2025
Check your lot numberHow we source this data

Summary

Viona Pharmaceuticals recalled Dapsone Gel 7 starting Dec 10, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0171-2025 on Jan 8, 2025. Reason: Crystallization. Status: Ongoing.

Why it was recalled

Crystallization

Product description

Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack

Lot numbers, UPCs & expiration codes

Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.

Where it was sold

US Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0171-2025
Classification
Class II
Status
Ongoing
Recall initiated
Dec 10, 2024
FDA report date
Jan 8, 2025
Quantity
23304 packs
Recall type
Voluntary: Firm initiated
Recalling firm
VIONA PHARMACEUTICALS INC

Original FDA data

Every field from FDA enforcement report D-0171-2025, exactly as published.

Show all FDA fields
City
Cranford
State
NJ
Status
Ongoing
Country
United States
Event ID
95930
Address
20 Commerce Dr Ste 340
Code information
Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.
Postal code
07016-3617
Report date
Jan 8, 2025
Product type
Drugs
Recall number
D-0171-2025
Classification
Class II
Recalling firm
VIONA PHARMACEUTICALS INC
Product quantity
23304 packs
Reason for recall
Crystallization
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack
Distribution pattern
US Nationwide
Recall initiation date
Dec 10, 2024
Initial firm notification
Letter
Center classification date
Jan 2, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0171-2025, published Jan 8, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls